3.5.0.2 html 18 249 1 false 0 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 000020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 000030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS PARENTHETICALS Sheet http://www.chinapharmaholdings.com/20160930/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICALS CONDENSED CONSOLIDATED BALANCE SHEETS PARENTHETICALS Statements 3 false false R4.htm 000040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Statements 4 false false R5.htm 000050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 5 false false R6.htm 000060 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES Notes 6 false false R7.htm 000070 - Disclosure - INVENTORY Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureINVENTORY INVENTORY Notes 7 false false R8.htm 000080 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosurePROPERTYANDEQUIPMENT PROPERTY AND EQUIPMENT Notes 8 false false R9.htm 000090 - Disclosure - INTANGIBLE ASSETS Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureINTANGIBLEASSETS INTANGIBLE ASSETS Notes 9 false false R10.htm 000100 - Disclosure - ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS. Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS. Notes 10 false false R11.htm 000110 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureRELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 000120 - Disclosure - NOTES PAYABLE Notes http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureNOTESPAYABLE NOTES PAYABLE Notes 12 false false R13.htm 000130 - Disclosure - BANKER'S ACCEPTANCE NOTES PAYABLE Notes http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureBANKERSACCEPTANCENOTESPAYABLE BANKER'S ACCEPTANCE NOTES PAYABLE Notes 13 false false R14.htm 000140 - Disclosure - CONSTRUCTION LOAN FACILITY Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureCONSTRUCTIONLOANFACILITY CONSTRUCTION LOAN FACILITY Notes 14 false false R15.htm 000150 - Disclosure - INCOME TAXES Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureINCOMETAXES INCOME TAXES Notes 15 false false R16.htm 000160 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureFAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 16 false false R17.htm 000170 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureSTOCKHOLDERSEQUITY STOCKHOLDERS' EQUITY Notes 17 false false R18.htm 000180 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureCOMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 000190 - Disclosure - CONCENTRATIONS Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureCONCENTRATIONS CONCENTRATIONS Notes 19 false false R20.htm 000200 - Disclosure - ACCOUNTING POLICIES (POLICIES) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureACCOUNTINGPOLICIESPOLICIES ACCOUNTING POLICIES (POLICIES) Notes 20 false false R21.htm 000210 - Disclosure - BASIC AND DILUTED LOSS PER COMMON SHARE (TABLES) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureBASICANDDILUTEDLOSSPERCOMMONSHARETABLES BASIC AND DILUTED LOSS PER COMMON SHARE (TABLES) Notes 21 false false R22.htm 000220 - Disclosure - INVENTORY (TABLES) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureINVENTORYTABLES INVENTORY (TABLES) Notes 22 false false R23.htm 000230 - Disclosure - PROPERTY AND EQUIPMENT (TABLES) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosurePROPERTYANDEQUIPMENTTABLES PROPERTY AND EQUIPMENT (TABLES) Notes 23 false false R24.htm 000240 - Disclosure - INTANGIBLE ASSETS (TABLES) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureINTANGIBLEASSETSTABLES INTANGIBLE ASSETS (TABLES) Notes 24 false false R25.htm 000250 - Disclosure - SCHEDULE OF CONSTRUCTION LOAN FACILITY (TABLES) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureSCHEDULEOFCONSTRUCTIONLOANFACILITYTABLES SCHEDULE OF CONSTRUCTION LOAN FACILITY (TABLES) Notes 25 false false R26.htm 000260 - Disclosure - INCOME TAXES (TABLES) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureINCOMETAXESTABLES INCOME TAXES (TABLES) Notes 26 false false R27.htm 000270 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS (TABLES) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DisclosureSCHEDULEOFFAIRVALUEMEASUREMENTSTABLES SCHEDULE OF FAIR VALUE MEASUREMENTS (TABLES) Notes 27 false false R28.htm 000280 - Statement - Organization and Nature of Operations (Details) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_OrganizationAndNatureOfOperationsDetails Organization and Nature of Operations (Details) Details 28 false false R29.htm 000290 - Statement - Trade Accounts Receivable and Allowance for Doubtful Accounts (Details) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_TradeAccountsReceivableAndAllowanceForDoubtfulAccountsDetails Trade Accounts Receivable and Allowance for Doubtful Accounts (Details) Details 29 false false R30.htm 000300 - Statement - Numerators and denominators used in the calculation of basic and diluted loss per share (Details) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_NumeratorsAndDenominatorsUsedInTheCalculationOfBasicAndDilutedLossPerShareDetails Numerators and denominators used in the calculation of basic and diluted loss per share (Details) Details 30 false false R31.htm 000310 - Statement - INVENTORY (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_INVENTORYDETAILS INVENTORY (DETAILS) Uncategorized 31 false false R32.htm 000320 - Statement - PROPERTY AND EQUIPMENT CONSISTED OF THE FOLLOWING (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_PROPERTYANDEQUIPMENTCONSISTEDOFTHEFOLLOWINGDETAILS PROPERTY AND EQUIPMENT CONSISTED OF THE FOLLOWING (DETAILS) Uncategorized 32 false false R33.htm 000330 - Statement - ESTIMATED USEFUL LIVES OF THE ASSETS AS FOLLOWS (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_ESTIMATEDUSEFULLIVESOFTHEASSETSASFOLLOWSDETAILS ESTIMATED USEFUL LIVES OF THE ASSETS AS FOLLOWS (DETAILS) Uncategorized 33 false false R34.htm 000340 - Statement - ASSETS DEPRECIATION (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_ASSETSDEPRECIATIONDETAILS ASSETS DEPRECIATION (DETAILS) Uncategorized 34 false false R35.htm 000350 - Statement - Intangible assets amortization expenses (Details) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_IntangibleAssetsAmortizationExpensesDetails Intangible assets amortization expenses (Details) Uncategorized 35 false false R36.htm 000360 - Statement - INTANGIBLE ASSETS CFDA APPROVED MEDICAL FORMULAS (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_INTANGIBLEASSETSCFDAAPPROVEDMEDICALFORMULASDETAILS INTANGIBLE ASSETS CFDA APPROVED MEDICAL FORMULAS (DETAILS) Uncategorized 36 false false R37.htm 000370 - Statement - ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_ADVANCESFORPURCHASESOFINTANGIBLEASSETSDETAILS ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS (DETAILS) Uncategorized 37 false false R38.htm 000380 - Statement - Interest (Details) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_InterestDetails Interest (Details) Uncategorized 38 false false R39.htm 000390 - Statement - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Uncategorized 39 false false R40.htm 000400 - Statement - NOTES PAYABLE (DETAILS) Notes http://www.chinapharmaholdings.com/20160930/role/idr_NOTESPAYABLEDETAILS NOTES PAYABLE (DETAILS) Uncategorized 40 false false R41.htm 000410 - Statement - BANKER'S ACCEPTANCE NOTES PAYABLE (Details) Notes http://www.chinapharmaholdings.com/20160930/role/idr_BANKERSACCEPTANCENOTESPAYABLEDetails BANKER'S ACCEPTANCE NOTES PAYABLE (Details) Uncategorized 41 false false R42.htm 000420 - Statement - CONSTRUCTION LOAN FACILITY (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_CONSTRUCTIONLOANFACILITYDETAILS CONSTRUCTION LOAN FACILITY (DETAILS) Uncategorized 42 false false R43.htm 000430 - Statement - PRINCIPAL PAYMENTS REQUIRED FOR THE NEXT FIVE YEARS ARE AS FOLLOWS: (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_PRINCIPALPAYMENTSREQUIREDFORTHENEXTFIVEYEARSAREASFOLLOWSDETAILS PRINCIPAL PAYMENTS REQUIRED FOR THE NEXT FIVE YEARS ARE AS FOLLOWS: (DETAILS) Uncategorized 43 false false R44.htm 000440 - Statement - SUBSIDY INCOME (Details) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_SUBSIDYINCOMEDetails SUBSIDY INCOME (Details) Uncategorized 44 false false R45.htm 000450 - Statement - ENTERPRISE INCOME TAX RATES (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_ENTERPRISEINCOMETAXRATESDETAILS ENTERPRISE INCOME TAX RATES (DETAILS) Uncategorized 45 false false R46.htm 000460 - Statement - PROVISION FOR INCOME TAXES (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_PROVISIONFORINCOMETAXESDETAILS PROVISION FOR INCOME TAXES (DETAILS) Uncategorized 46 false false R47.htm 000470 - Statement - DEFERRED INCOME TAX ASSETS AND LIABILITY (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_DEFERREDINCOMETAXASSETSANDLIABILITYDETAILS DEFERRED INCOME TAX ASSETS AND LIABILITY (DETAILS) Uncategorized 47 false false R48.htm 000480 - Statement - FAIR VALUE MEASUREMENTS AT REPORTING DATE USING (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_FAIRVALUEMEASUREMENTSATREPORTINGDATEUSINGDETAILS FAIR VALUE MEASUREMENTS AT REPORTING DATE USING (DETAILS) Uncategorized 48 false false R49.htm 000490 - Statement - CAPITAL STOCK TRANSACTIONS (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_CAPITALSTOCKTRANSACTIONSDETAILS CAPITAL STOCK TRANSACTIONS (DETAILS) Uncategorized 49 false false R50.htm 000500 - Statement - CONCENTRATIONS (DETAILS) Sheet http://www.chinapharmaholdings.com/20160930/role/idr_CONCENTRATIONSDETAILS CONCENTRATIONS (DETAILS) Uncategorized 50 false false All Reports Book All Reports cphi-20160930.xml cphi-20160930.xsd cphi-20160930_cal.xml cphi-20160930_def.xml cphi-20160930_lab.xml cphi-20160930_pre.xml true true